DK2555787T3 - Formulering af curcumin med forbedret biotilgængelighed af curcumin samt fremgangsmåde til fremstilling deraf og behandling dermed - Google Patents
Formulering af curcumin med forbedret biotilgængelighed af curcumin samt fremgangsmåde til fremstilling deraf og behandling dermedInfo
- Publication number
- DK2555787T3 DK2555787T3 DK11765166.1T DK11765166T DK2555787T3 DK 2555787 T3 DK2555787 T3 DK 2555787T3 DK 11765166 T DK11765166 T DK 11765166T DK 2555787 T3 DK2555787 T3 DK 2555787T3
- Authority
- DK
- Denmark
- Prior art keywords
- curcumin
- formulation
- preparation
- treatment
- well
- Prior art date
Links
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 title abstract 12
- 235000012754 curcumin Nutrition 0.000 title abstract 6
- 229940109262 curcumin Drugs 0.000 title abstract 6
- 239000004148 curcumin Substances 0.000 title abstract 6
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 title abstract 6
- 238000009472 formulation Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 235000003392 Curcuma domestica Nutrition 0.000 abstract 3
- 244000008991 Curcuma longa Species 0.000 abstract 3
- 229930153442 Curcuminoid Natural products 0.000 abstract 3
- 235000003373 curcuma longa Nutrition 0.000 abstract 3
- 235000013976 turmeric Nutrition 0.000 abstract 3
- 239000000341 volatile oil Substances 0.000 abstract 3
- 239000000470 constituent Substances 0.000 abstract 2
- NAAJVHHFAXWBOK-ZDUSSCGKSA-N (+)-(S)-ar-turmerone Chemical compound CC(C)=CC(=O)C[C@H](C)C1=CC=C(C)C=C1 NAAJVHHFAXWBOK-ZDUSSCGKSA-N 0.000 abstract 1
- XOCANRBEOZQNAQ-KGLIPLIRSA-N ar-turmerone Natural products C[C@H](CC(=O)C=C(C)C)[C@@H]1CC=C(C)C=C1 XOCANRBEOZQNAQ-KGLIPLIRSA-N 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000009469 supplementation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Mycology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN950CH2010 | 2010-04-05 | ||
| PCT/IN2011/000232 WO2011125070A2 (en) | 2010-04-05 | 2011-04-04 | Formulation of curcumin with enhanced bioavailability of curcumin and method of preparation and treatment thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2555787T3 true DK2555787T3 (da) | 2018-01-29 |
Family
ID=44763344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK11765166.1T DK2555787T3 (da) | 2010-04-05 | 2011-04-04 | Formulering af curcumin med forbedret biotilgængelighed af curcumin samt fremgangsmåde til fremstilling deraf og behandling dermed |
Country Status (6)
| Country | Link |
|---|---|
| EP (2) | EP2555787B1 (OSRAM) |
| DK (1) | DK2555787T3 (OSRAM) |
| ES (1) | ES2657364T3 (OSRAM) |
| NO (1) | NO2555787T3 (OSRAM) |
| PL (1) | PL2555787T3 (OSRAM) |
| WO (1) | WO2011125070A2 (OSRAM) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN2013CH00226A (OSRAM) * | 2013-01-17 | 2015-08-07 | Benny Antony | |
| WO2014068597A2 (en) * | 2012-11-03 | 2014-05-08 | Benny Antony | Formulation of curcumin with enhanced bioavailability of curcumin and method of preparation and treatment thereof |
| GB201111319D0 (en) * | 2011-07-04 | 2011-08-17 | Univ Leuven Kath | Anticonvulsant activity of tumeric oil and bisabolene sesquiterpenoids of curcuma longa |
| CN102697887A (zh) * | 2012-06-26 | 2012-10-03 | 南京辰逸生物科技有限公司 | 一种治疗类风湿性关节炎的中药组合物 |
| WO2015118557A1 (en) | 2014-02-05 | 2015-08-13 | Laila Nutraceuticals | Synergistic dietary supplement compositions for the prevention, treatment or control of inflammatory disorders |
| BE1024442B1 (nl) * | 2016-07-27 | 2018-02-28 | Nutrisan Nv | Samenstelling en gebruik van een voedingssupplement |
| KR102786957B1 (ko) | 2018-09-26 | 2025-03-26 | 뉴트리벤티아 리미티드 | 커큐미노이드 복합물 |
| CN111991376B (zh) * | 2020-08-26 | 2022-12-16 | 广东工业大学 | 芳姜黄酮在制备防治溃疡性结肠炎及调节肠道菌群的产品中的应用 |
| WO2022115063A1 (en) * | 2020-11-30 | 2022-06-02 | Kavak Çi̇ftci̇ Gida İçecek Organi̇k Gübre Sanayi̇ Ve Ti̇caret Li̇mi̇ted Şi̇rketi̇ | A composition of a food supplement and production method thereof |
| US12251415B1 (en) | 2024-01-18 | 2025-03-18 | Arjuna Natural Private Limited | Curcuminoid composition of curcumin-keto, method of preparation and use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1274300C (zh) * | 2003-12-11 | 2006-09-13 | 中国科学院生物物理研究所 | 用于改善姜黄素溶出度和生物利用度的药物组合物及其制备方法 |
| CN1568944A (zh) * | 2004-04-28 | 2005-01-26 | 广西南宁邕江药业有限公司 | 姜黄素及其衍生物用于制备治疗抑郁症药物的应用 |
| PL1890546T3 (pl) * | 2005-05-30 | 2019-04-30 | Benny Antony | Sposób poprawiania biodostępności kurkuminy |
| US7883728B2 (en) * | 2005-05-30 | 2011-02-08 | Arjuna Natural Extracts, Ltd. | Composition to enhance the bioavailability of curcumin |
-
2011
- 2011-04-04 WO PCT/IN2011/000232 patent/WO2011125070A2/en not_active Ceased
- 2011-04-04 PL PL11765166T patent/PL2555787T3/pl unknown
- 2011-04-04 NO NO11765166A patent/NO2555787T3/no unknown
- 2011-04-04 DK DK11765166.1T patent/DK2555787T3/da active
- 2011-04-04 EP EP11765166.1A patent/EP2555787B1/en active Active
- 2011-04-04 EP EP17193479.7A patent/EP3290045A1/en not_active Withdrawn
- 2011-04-04 ES ES11765166.1T patent/ES2657364T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2657364T3 (es) | 2018-03-05 |
| WO2011125070A2 (en) | 2011-10-13 |
| EP2555787A2 (en) | 2013-02-13 |
| EP2555787B1 (en) | 2017-11-08 |
| NO2555787T3 (OSRAM) | 2018-04-07 |
| EP2555787A4 (en) | 2013-10-23 |
| EP3290045A1 (en) | 2018-03-07 |
| WO2011125070A3 (en) | 2011-12-08 |
| PL2555787T3 (pl) | 2018-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2555787T3 (da) | Formulering af curcumin med forbedret biotilgængelighed af curcumin samt fremgangsmåde til fremstilling deraf og behandling dermed | |
| EA201892050A1 (ru) | Способ получения замещенных 5-фтор-1h-пиразолопиридинов | |
| ECSP13012668A (es) | Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso | |
| BR112014003681A2 (pt) | composto, composição farmacêutica, produto de combinação farmacêutica, uso de um composto, e, método para tratar doenças ou condições | |
| HK1210782A1 (en) | Lfa-1 inhibitor and polymorph thereof | |
| ECSP10010295A (es) | Formulacion de anticuerpo | |
| BR112014007203A2 (pt) | composto, composição farmacêutica, método de tratamento, utilização de um composto, conjunto e invenção | |
| WO2011161226A3 (en) | Novel antibody formulation | |
| BR112015011112A2 (pt) | composto oligomérico, oligômero, composição farmacêutica, uso do composto oligomérico, método de síntese de um composto oligomérico e método de tratamento de uma doença. | |
| BR112014011671A2 (pt) | composto, composição farmacêutica, método para o tratamento de uma doença ou condição, e, uso de um composto | |
| CL2014000467A1 (es) | Formulación que comprende cepa bacteriana aislada del genero burkholderia y metabolitos plaguicidas derivados; metodo para obtener sustancia efectiva como plaguicida derivada de la formulación antes indicada. | |
| BR112013015010A2 (pt) | produto, substrato, composição farmacêutica, uso de um produto, e, método para tratar uma infecção microbiana | |
| BR112013015855A2 (pt) | composto, uso de um composto, métodos de prevenção, tratamento, melhora ou profilaxia de distúrbios fisiológicos ou doenças, e de tratamento ou melhora de indicações cosméticas, e, composição farmacêutica. | |
| BR112014010186A2 (pt) | formulação farmacêutica estável, kit, composição farmacêutica, método para preparar uma formulação farmacêutica, e, método para tratar um humano ou animal | |
| WO2012129341A3 (en) | Disease detection in plants | |
| BR112012023355A2 (pt) | composto, composição farmacêutica e método de ruptura da interação nek2/hec1 | |
| EP3279207A4 (en) | Novel compound of 4'-thionucleoside, as well as preparation method therefor, pharmaceutical composition thereof and application thereof | |
| BR112014026149A2 (pt) | método para a preparação de 2,4-ácido dihidroxibutírico (2,4-dhb) e microrganismo. | |
| WO2012049307A3 (en) | Novel n-terminally modified insulin derivatives | |
| WO2011150201A3 (en) | Azolyl amide compounds and methods of use thereof | |
| WO2012103810A1 (en) | Certain chemical entities, compositions, and methods | |
| BR112012029606A2 (pt) | formulação, método para a fabricação de uma fomulação, método de tratamento de uma planta e uso de uma formulação | |
| BR112014000347A2 (pt) | método para melhorar o aroma de um alimento, bebida, produto farmacêutico ou produto para o cuidado oral, e, alimento, bebida, produto farmacêutico ou produto para o cuidado oral | |
| ECSP13012666A (es) | Formulacion en comprimidos difusibles y flotantes de un pesticida | |
| WO2012017323A3 (en) | Pharmaceutical composition and methods of treating and preventing the diseases caused by hiv or associated with hiv |